Filing Details
- Accession Number:
- 0001790300-24-000009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-14 18:06:00
- Reporting Period:
- 2024-11-08
- Accepted Time:
- 2024-11-14 18:06:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1754195 | Trulieve Cannabis Corp. | TRUL | Medicinal Chemicals & Botanical Products (2833) | 581882476 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2044797 | Nilyum Jhala | C/O Trulieve Cannabis Corp. 6749 Ben Bostic Road Quincy FL 32351 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Subordinate Voting Shares | Acquisiton | 2024-11-08 | 1,500 | $6.98 | 1,500 | No | 4 | P | Indirect | By Spouse |
Subordinate Voting Shares | Acquisiton | 2024-11-11 | 2,000 | $5.70 | 3,500 | No | 4 | P | Indirect | By Spouse |
Subordinate Voting Shares | Acquisiton | 2024-11-12 | 2,500 | $6.32 | 6,000 | No | 4 | P | Indirect | By Spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Spouse |
No | 4 | P | Indirect | By Spouse |
No | 4 | P | Indirect | By Spouse |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Subordinate Voting Shares | 114,778 | Direct |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.95 to $7.04, inclusive. The reporting person undertakes to provide to the issuer, any securityholder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.